1 / 19

TOC - Global Ligase Market

The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.

bisreports
Download Presentation

TOC - Global Ligase Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ligase Market - A Global and Regional Analysis Table of Content Focus on Product, Source, Application, End User, and Country GLOBAL LIGASE MARKET Analysis and Forecast: 2022-2032 June 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Copyright © 2022 BIS Research Inc. GLOBAL LIGASE MARKET All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 18 1.Market ....................................................................................... 24 1.1 Product Definition ............................................................................................ 25 1.1.1Inclusion and Exclusion ............................................................................. 25 1.2 Ligase Market Workflow .................................................................................. 25 1.3 Market Scope ................................................................................................... 26 1.3.1Scope of the Study ...................................................................................... 26 1.3.2Key Questions Answered in the Report .................................................... 26 2.Research Methodology .............................................................. 28 2.1 Global Ligase Market: Research Methodology ............................................. 29 2.2 Data Sources .................................................................................................... 29 2.2.1Primary Data Sources ................................................................................. 29 2.2.2Secondary Data Sources ............................................................................ 30 2.3 Market Estimation Model ................................................................................. 31 Criteria for Company Profiling ........................................................................ 33 3.Global Ligase Market: Market Overview ..................................... 34 2.4 3.1 Overview ........................................................................................................... 35 3.2 Market Footprint and Growth Potential, $Million, 2021-2032 ....................... 35 3.3 COVID-19 Impact on Global Ligase Market ................................................... 36 3.3.1Impact on Market Growth Due to COVID-19 .............................................. 36 4.Industry Analysis ....................................................................... 37 4.1 Regulatory Framework Overview ................................................................... 38 4.1.1Regulatory Guidelines of Ligase Enzymes ............................................... 38 GLOBAL LIGASE MARKET 4.1.1.1 Regulatory Framework in the U.S. ..................................................................... 38 4.1.1.2 Regulatory Framework in the European Union .................................................. 39 4.2 Patent Analysis ................................................................................................ 39 4.2.1By Region ..................................................................................................... 39 4.2.2By Year ......................................................................................................... 40 3 All rights reserved at BIS Research Inc.

  4. 5.Market Dynamics ....................................................................... 41 5.1 Overview ........................................................................................................... 42 5.2 Impact Analysis ............................................................................................... 42 5.3 Market Drivers .................................................................................................. 43 5.3.1Growing Need for Ligases in Disease Treatment ..................................... 43 5.3.2Rising Incidence of Diseases such as Cancer and Genetic Disorders ...................................................................................................... 44 5.3.3Rising Focus of Researchers on Non-Toxic Biocatalyst ......................... 44 5.4 Market Restraints ............................................................................................. 45 5.4.1High Reception Costs Involving Small and Medium Enterprises ............ 45 5.4.2Variation in the Ability of Ligase to Repair ............................................... 45 5.5 Market Opportunities ....................................................................................... 45 5.5.1Utilization of PCR-Based Frameworks ...................................................... 45 5.5.2Recuperation of Lost or Rearranged Genetic Information ...................... 46 6.Competitive Landscape ............................................................. 47 6.1 Competitive Landscape .................................................................................. 48 6.1.1Mergers and Acquisitions ........................................................................... 48 6.1.2Synergistic Activities .................................................................................. 49 6.1.3Product Launches ....................................................................................... 50 6.1.4Fundings and Expansions .......................................................................... 50 6.2 Supply Chain Analysis .................................................................................... 50 6.3 Pricing Analysis (by Product) ......................................................................... 52 6.3.1Market Share Analysis (2021) ..................................................................... 52 6.3.2Growth-Share Analysis (2021) .................................................................... 53 6.3.2.1 Growth-Share Analysis by Company ................................................................. 53 GLOBAL LIGASE MARKET 6.3.2.2 Growth-Share Analysis by Application Type ...................................................... 55 6.3.2.3 Growth-Share Analysis by End User ................................................................. 56 7.Global Ligase Market (by Product Type), Value ($Million) & Volume (Units), 2021-2032 ......................................................... 58 7.1 Product Outlook ............................................................................................... 59 4 All rights reserved at BIS Research Inc.

  5. 7.1.1Quick Ligase ................................................................................................ 59 7.1.2T4 DNA Ligase ............................................................................................. 61 7.1.3E. coli DNA Ligase ....................................................................................... 63 7.1.4Tth DNA Ligase ............................................................................................ 65 7.1.5T4 RNA Ligase ............................................................................................. 67 7.1.6Pfu DNA Ligase............................................................................................ 69 7.1.7Others ........................................................................................................... 70 8.Global Ligase Market (by Source Type), Value ($Million), 2021- 2032 .......................................................................................... 73 8.1 Source Outlook ................................................................................................ 74 8.1.1Archaebacterium ......................................................................................... 74 8.1.2Escherichia coli ........................................................................................... 75 8.1.3Thermus thermophilus ................................................................................ 76 8.1.4Pyrococcus furiosus ................................................................................... 77 8.1.5Others ........................................................................................................... 78 9.Global Ligase Market (by Application), Value ($Million), 2021- 2032 .......................................................................................... 79 9.1 Application Outlook ......................................................................................... 80 9.1.1Ligase Chain Reaction (LCR) ..................................................................... 80 9.1.2Ligase Detection Reaction (LDR) ............................................................... 81 9.1.3Next-Generation Sequencing (NGS) .......................................................... 82 9.1.4Repeat Expansion Detection (RED) ........................................................... 83 9.1.5Rolling Circle Amplification (RCA) ............................................................. 84 9.1.6Proximity Ligation Assay (PLA) ................................................................. 85 9.1.7Molecular Cloning ....................................................................................... 86 9.1.8Ligation Mediated PCR ............................................................................... 88 GLOBAL LIGASE MARKET 9.1.9Mutation Detection ...................................................................................... 89 9.1.10Others ........................................................................................................... 90 10.Global Ligase Market (by End User), Value ($Million) & Volume (Units), 2021-2032 ..................................................................... 91 5 All rights reserved at BIS Research Inc.

  6. 10.1End User Outlook ............................................................................................ 92 10.1.1Research Laboratories and Institutions .................................................... 92 10.1.2Pharmaceutical and Biopharmaceutical Companies ............................... 93 10.1.3Diagnostic Laboratories ............................................................................. 95 10.1.4Others ........................................................................................................... 96 11.Global Ligase Market (by Region), Value ($Million) & Volume (Units), 2021-2032 ..................................................................... 98 11.1Regional Outlook ............................................................................................. 99 11.2North America ................................................................................................ 100 11.2.1Key Dynamics ............................................................................................ 101 11.2.2U.S .............................................................................................................. 101 11.2.3Canada ....................................................................................................... 103 11.3Europe ............................................................................................................ 104 11.3.1Key Dynamics ............................................................................................ 106 11.3.2France ......................................................................................................... 106 11.3.3Germany ..................................................................................................... 108 11.3.4U.K. ............................................................................................................. 109 11.3.5Italy ............................................................................................................. 111 11.3.6Spain ........................................................................................................... 112 11.3.7Rest-of-Europe........................................................................................... 114 11.4Asia-Pacific (APAC) ....................................................................................... 115 11.4.1Key Dynamics ............................................................................................ 116 11.4.2China .......................................................................................................... 117 11.4.3Japan .......................................................................................................... 118 11.4.4India ............................................................................................................ 120 GLOBAL LIGASE MARKET 11.4.5Australia ..................................................................................................... 121 11.4.6South Korea ............................................................................................... 123 11.4.7Rest-of-Asia-Pacific ................................................................................... 124 11.5Latin America (LATAM) ................................................................................. 126 11.5.1Key Dynamics ............................................................................................ 127 6 All rights reserved at BIS Research Inc.

  7. 11.5.2Brazil ........................................................................................................... 127 11.5.3Mexico ........................................................................................................ 129 11.5.4Rest-of-the-LATAM .................................................................................... 130 11.6Rest-of-the-World .......................................................................................... 132 12.Company Profiles ..................................................................... 134 12.1Agilent Technologies, Inc. ............................................................................ 135 12.1.1Company Overview ................................................................................... 135 12.1.2Role of Agilent Technologies, Inc. in the Global Ligase Market ............ 135 12.1.3Key Competitors of the Company ............................................................ 135 12.1.4Key Customers of the Company .............................................................. 135 12.1.5Financials ................................................................................................... 136 12.1.6Analyst Perspective .................................................................................. 139 12.2ArcticZymes Technologies ASA ................................................................... 140 12.2.1Company Overview ................................................................................... 140 12.2.2Role of ArcticZymes Technologies ASA in the Global Ligase Market .................................................................................................................... 140 12.2.3Key Competitors of the Company ............................................................ 140 12.2.4Key Customers of the Company .............................................................. 140 12.2.5Corporate Strategies ................................................................................. 141 12.2.6Financials ................................................................................................... 142 12.2.7Analyst Perspective .................................................................................. 144 12.3BD ................................................................................................................... 145 12.3.1Company Overview ................................................................................... 145 12.3.2Role of BD in the Global Ligase Market ................................................... 145 12.3.3Key Competitors of the Company ............................................................ 145 GLOBAL LIGASE MARKET 12.3.4Key Customers of the Company .............................................................. 146 12.3.5Financials ................................................................................................... 146 12.3.6Analyst Perspective .................................................................................. 148 12.4Bio-Rad Laboratories, Inc. ............................................................................ 149 12.4.1Company Overview ................................................................................... 149 7 All rights reserved at BIS Research Inc.

  8. 12.4.2Role of Bio-Rad Laboratories, Inc. in the Global Ligase Market ........... 149 12.4.3Key Competitors of the Company ............................................................ 149 12.4.4Key Customers of the Company .............................................................. 149 12.4.5Financials ................................................................................................... 150 12.4.6Analyst Perspective .................................................................................. 153 12.5Codexis, Inc. ................................................................................................... 154 12.5.1Company Overview ................................................................................... 154 12.5.2Role of Codexis, Inc. in the Global Ligase Market .................................. 154 12.5.3Key Competitors of the Company ............................................................ 154 12.5.4Key Customers of the Company .............................................................. 154 12.5.5Corporate Strategies ................................................................................. 155 12.5.6Financials ................................................................................................... 156 12.5.7Analyst Perspective .................................................................................. 158 12.6F. Hoffmann-La Roche Ltd. ........................................................................... 159 12.6.1Company Overview ................................................................................... 159 12.6.2Role of F. Hoffmann-La Roche Ltd. in the Global Ligase Market .......... 159 12.6.3Key Competitors of the Company ............................................................ 159 12.6.4Key Customers of the Company .............................................................. 159 12.6.5Corporate Strategies ................................................................................. 160 12.6.6Financials ................................................................................................... 160 12.6.7Analyst Perspective .................................................................................. 163 12.7Inspiralis Limited, Inc. ................................................................................... 164 12.7.1Company Overview ................................................................................... 164 12.7.2Role of Inspiralis Limited, Inc. in the Global Ligase Market .................. 164 12.7.3Key Competitors of the Company ............................................................ 164 GLOBAL LIGASE MARKET 12.7.4Key Customers of the Company .............................................................. 164 12.7.5Analyst Perspective .................................................................................. 165 12.8Merck KGaA ................................................................................................... 166 12.8.1Company Overview ................................................................................... 166 12.8.2Role of Merck KGaA in the Global Ligase Market ................................... 166 8 All rights reserved at BIS Research Inc.

  9. 12.8.3Key Competitors of the Company ............................................................ 166 12.8.4Key Customers of the Company .............................................................. 166 12.8.5Corporate Strategies ................................................................................. 167 12.8.6Financials ................................................................................................... 167 12.8.7Analyst Perspective .................................................................................. 170 12.9New England Biolabs (UK) Ltd. .................................................................... 171 12.9.1Company Overview ................................................................................... 171 12.9.2Role of New England Biolabs (UK) Ltd. In the Global Ligase Market ... 171 12.9.3Key Competitors of the Company ............................................................ 171 12.9.4Analyst Perspective .................................................................................. 172 12.10Promega Corporation .................................................................................... 173 12.10.1 Company Overview ............................................................................. 173 12.10.2 Role of Promega Corporation in the Global Ligase Market ............. 173 12.10.3 Key Competitors of the Company ..................................................... 173 12.10.4 Analyst Perspective ............................................................................ 174 12.11QIAGEN N.V. ................................................................................................... 175 12.11.1 Company Overview ............................................................................. 175 12.11.2 Role of QIAGEN N.V. in the Global Ligase Market ........................... 175 12.11.3 Key Competitors of the Company ..................................................... 175 12.11.4 Key Customers of the Company ........................................................ 175 12.11.5 Corporate strategies ........................................................................... 176 12.11.6 Financials ............................................................................................ 177 12.11.7 Analyst Perspective ............................................................................ 179 12.12SBS Genetech ................................................................................................ 180 12.12.1 Company Overview ............................................................................. 180 GLOBAL LIGASE MARKET 12.12.2 Role of SBS Genetech in the Global Ligase Market ......................... 180 12.12.3 Key Competitors of the Company ..................................................... 180 12.12.4 Key Customers of the Company ........................................................ 180 12.12.5 Analyst Perspective ............................................................................ 181 12.13Takara Bio Inc. ............................................................................................... 182 9 All rights reserved at BIS Research Inc.

  10. 12.13.1 Company Overview ............................................................................. 182 12.13.2 Role of Takara Bio Inc. in the Global Ligase Market ........................ 182 12.13.3 Key Competitors of the Company ..................................................... 182 12.13.4 Key Customers of the Company ........................................................ 182 12.13.5 Financials ............................................................................................ 183 12.13.6 Analyst Perspective ............................................................................ 186 12.14Thermo Fisher Scientific, Inc. ....................................................................... 187 12.14.1 Company Overview ............................................................................. 187 12.14.2 Role of Thermo Fisher Scientific, Inc. in the Global Ligase Market ......................................................................................................... 187 12.14.3 Key Competitors of the Company ..................................................... 187 12.14.4 Key Customers of the Company ........................................................ 187 12.14.5 Financials ............................................................................................ 188 12.14.6 Analyst Perspective ............................................................................ 191 12.15Emerging Companies .................................................................................... 192 12.15.1 Tinzyme Ltd. ........................................................................................ 192 12.15.2 Hotspot Therapeutics ......................................................................... 192 12.15.3 Nurix Therapeutics .............................................................................. 193 12.15.4 Vividion Therapeutics ......................................................................... 193 GLOBAL LIGASE MARKET 10 All rights reserved at BIS Research Inc.

  11. List of Figures Figure 1: Growth Strategy by Companies Figure 2: Top Eight Infectious Diseases by Disability-Adjusted Life Years (DALY) Figure 3: Global Ligase Market (by Product), $Million, 2021 and 2032 Figure 4: Global Ligase Market (by Source), $Million, 2021 and 2032 Figure 5: Global Ligase Market (by Application), 2021 and 2032 Figure 6: Global Ligase Market (by End User), $Million, 2021 and 2032 Figure 7: Global Ligase Market Snapshot Figure 8: Ligase Market Workflow Figure 9: Global Ligase Market Segmentation Figure 10: Global Ligase Market: Research Methodology Figure 11: Primary Research Methodology Figure 12: Bottom-Up Approach (Segment-Wise Analysis) Figure 13: Top-Down Approach (Segment-Wise Analysis) Figure 14: Global Ligase Market, $Million, 2021-2032 Figure 15: Region-Wise Analysis (January 2019-June 2022) of Patents Related to the Global Ligase market Figure 16: Year-Wise Analysis (January 2019-June 2022) of Patents Related to the Global Ligase market Figure 17: Market Dynamics Figure 18: Likert Scale Figure 19: Impact Analysis Figure 20: Alzheimer’s Disease Prevalence in the Year 2019 in Men Population Figure 21: List of Ligase Type with Respect to Disease Type Figure 22: Share of Key Developments and Strategies, January 2019-January 2022 Figure 23: Share of Acquisitions (by Company), January 2019-January 2022 Figure 24: Synergistic Activities Share (by Company), January 2019-January 2022 Figure 25: Product Launches (by Company), January 2019-January 2022 GLOBAL LIGASE MARKET Figure 26: Share of Funding Activities (by Company), January 2019-January 2022 Figure 27: Supply Chain Analysis of the Global Ligase Market Figure 28: Market Share Analysis for Global Ligase Market, $Million, 2021 Figure 29: Growth-Share Analysis of the Global Ligase Market (by Company), 2021 Figure 30: Growth-Share Matrix for Global Ligase Market (by Application Type), 2021 11 All rights reserved at BIS Research Inc.

  12. Figure 31: Growth-Share Matrix for Global Ligase Market (by End User), 2021 Figure 32: Global Ligase Market (Quick Ligase), $Million, 2021-2032 Figure 33: Global Ligase Market (Quick Ligase), Million Units, 2021-2032 Figure 34: Global Ligase Market (T4 DNA Ligase), $Million, 2021-2032 Figure 35: Global Ligase Market (T4 DNA Ligase), Million Units, 2021-2032 Figure 36: Global Ligase Market (E. coli Ligase), $Million, 2021-2032 Figure 37: Global Ligase Market (E. coli Ligase), Million Units, 2021-2032 Figure 38: Global Ligase Market (Tth DNA Ligase), $Million, 2021-2032 Figure 39: Global Ligase Market (Tth DNA Ligase), Million Units, 2021-2032 Figure 40: Global Ligase Market (T4 RNA Ligase), $Million, 2021-2032 Figure 41: Global Ligase Market (T4 RNA Ligase), Million Units, 2021-2032 Figure 42: Global Ligase Market (Pfu DNA Ligase), $Million, 2021-2032 Figure 43: Global Ligase Market (Pfu DNA Ligase), Million Units, 2021-2032 Figure 44: Global Ligase Market (Others), $Million, 2021-2032 Figure 45: Global Ligase Market (Others), Million Units, 2021-2032 Figure 46: Global Ligase Market (Archaebacterium), $Million, 2021-2032 Figure 47: Global Ligase Market (E. coli), $Million, 2021-2032 Figure 48: Global Ligase Market (Thermus Thermophillus), $Million, 2021-2032 Figure 49: Global Ligase Market (Pyrococcus furiosus), $Million, 2021-2032 Figure 50: Global Ligase Market (Others), $Million, 2021-2032 Figure 51: Global Ligase Market (Ligase Chain Reaction), $Million, 2021-2032 Figure 52: Global Ligase Market (Ligase Detection Reaction), $Million, 2021-2032 Figure 53: Global Ligase Market (Next-Generation Sequencing), $Million, 2021-2032 Figure 54: Global Ligase Market (Repeat Expansion Detection), $Million, 2021-2032 Figure 55: Global Ligase Market (Rolling Circle Amplification), $Million, 2021-2032 Figure 56: Global Ligase Market (Proximity Ligation Assay), $Million, 2021-2032 Figure 57: Global Ligase Market (Molecular Cloning), $Million, 2021-2032 Figure 58: Global Ligase Market (Ligation Mediated PCR), $Million, 2021-2032 GLOBAL LIGASE MARKET Figure 59: Global Ligase Market (Mutation Detection), $Million, 2021-2032 Figure 60: Global Ligase Market (Others), $Million, 2021-2032 Figure 61: Global Ligase Market (Research Laboratories and Institutions), $Million, 2021-2032 Figure 62: Global Ligase Market (Research Laboratories and Institutions), Million Units, 2021-2032 12 All rights reserved at BIS Research Inc.

  13. Figure 63: Global Ligase Market (Pharmaceutical and Biopharmaceutical Companies), $Million, 2021- 2032 Figure 64: Global Ligase Market (Pharmaceutical and Biopharmaceutical Companies), Million Units, 2021-2032 Figure 65: Global Ligase Market (Diagnostic Laboratories), $Million, 2021-2032 Figure 66: Global Ligase Market (Diagnostic Laboratories), Million Units, 2021-2032 Figure 67: Global Ligase Market (Others), $Million, 2021-2032 Figure 68: Global Ligase Market (Others), Million Units, 2021-2032 Figure 69: Global Ligase Market Snapshot (by Region) Figure 70: Growth Potential Analysis (by Country) Figure 71: North America: Market Dynamics Figure 72: U.S. Ligase Market, $Million, 2021-2032 Figure 73: Canada Ligase Market, $Million, 2021-2032 Figure 74: Growth Potential Analysis (by Country) Figure 75: Europe: Market Dynamics Figure 76: France Ligase Market, $Million, 2021-2032 Figure 77: Germany Ligase Market, $Million, 2021-2032 Figure 78: U.K. Ligase Market, $Million, 2021-2032 Figure 79: Italy Ligase Market, $Million, 2021-2032 Figure 80: Spain Ligase Market, $Million, 2021-2032 Figure 81: Rest-of-Europe Ligase Market, $Million, 2021-2032 Figure 82: Growth Potential Analysis (by Country) Figure 83: APAC: Market Dynamics Figure 84: China Ligase Market, $Million, 2021-2032 Figure 85: Japan Ligase Market, $Million, 2021-2032 Figure 86: India Ligase Market, $Million, 2021-2032 Figure 87: Ligase Market, $Million, 2021-2032 Figure 88: South Korea Ligase Market, $Million, 2021-2032 GLOBAL LIGASE MARKET Figure 89: Rest-of-Asia-Pacific Ligase Market, $Million, 2021-2032 Figure 90: Growth Potential Analysis (by Country) Figure 91: LATAM: Market Dynamics Figure 92: Brazil Ligase Market, $Million, 2021-2032 Figure 93: Mexico Ligase Market, $Million, 2021-2032 13 All rights reserved at BIS Research Inc.

  14. Figure 94: Rest-of-the-LATAM Ligase Market, $Million, 2021-2032 Figure 95: Rest-of-the-World Ligase Market, $Million, 2021-2032 Figure 96: Agilent Technologies, Inc.: Product Portfolio Figure 97: Agilent Technologies, Inc.: Overall Financial 2019-2021 Figure 98: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 99: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 100: Agilent Technologies, Inc: R&D Expenditure, $Million, 2019-2021 Figure 101: ArcticZymes Technologies ASA: Product Portfolio Figure 102: ArcticZymes Technologies ASA: Overall Financials, 2019-2021 Figure 103: ArcticZymes Technologies ASA: Revenue (by Segment), $Million, 2019-2021 Figure 104: ArcticZymes Technologies ASA: R&D Expenditure, $Million, 2019-2021 Figure 105: BD.: Product Portfolio Figure 106: BD.: Overall Financials, 2019-2021 Figure 107: BD.: Revenue (by Segment), $Million, 2019-2021 Figure 108: BD.: Revenue (by Region), $Million, 2019-2021 Figure 109: BD.: R&D Expenditure, $Million, 2019-2021 Figure 110: Bio-Rad Laboratories, Inc.: Product Portfolio Figure 111: Bio-Rad Laboratories, Inc.: Overall Financials, 2019-2021 Figure 112: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 113: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 114: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 115: Codexis, Inc.: Product Portfolio Figure 116: Codexis, Inc.: Overall Financials, 2019-2021 Figure 117: Codexis, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 118: Codexis, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 119: Codexis, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 120: F. Hoffmann-La Roche Ltd.: Product Portfolio Figure 121: F. Hoffmann-La Roche Ltd.: Overall Financials, 2019-2021 GLOBAL LIGASE MARKET Figure 122: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021 Figure 123: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021 Figure 124: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021 Figure 125: Inspiralis Limited, Inc.: Product Portfolio Figure 126: Merck KGaA: Product Portfolio 14 All rights reserved at BIS Research Inc.

  15. Figure 127: Merck KGaA: Overall Financials, $Million, 2019-2021 Figure 128: Merck KGaA: Revenue (by Segment), $Million, 2019-2021 Figure 129: Merck KGaA: Revenue (by Region), $Million, 2019-2021 Figure 130: Merck KGaA: R&D Expenditure, $Million, 2019-2021 Figure 131: New England Biolabs (UK) Ltd.: Product Portfolio Figure 132: Promega Corporation: Product Portfolio Figure 133: QIAGEN N.V.: Product Portfolio Figure 134: QIAGEN N.V.: Overall Financials, 2019-2021 Figure 135: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021 Figure 136: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021 Figure 137: QIAGEN N.V.: R&D Expenditure, 2019-2021 Figure 138: SBS Genetech: Product Portfolio Figure 139: Takara Bio Inc.: Product Portfolio Figure 140: Takara Bio Inc.: Overall Financials, 2019-2021 Figure 141: Takara Bio Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 142: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2021 Figure 143: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2021 Figure 144: Thermo Fisher Scientific, Inc.: Product Portfolio Figure 145: Thermo Fisher Scientific, Inc.: Overall Financials, 2019-2021 Figure 146: Thermo Fisher Scientific, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 147: Thermo Fisher Scientific, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 148: Thermo Fisher Scientific, Inc.: R&D Expenditure, $Million, 2019-2021 GLOBAL LIGASE MARKET 15 All rights reserved at BIS Research Inc.

  16. List of Tables Table 1: COVID-19 Impact on Global Ligase Market Table 2: Companies Providing Quick Ligase Kits Table 3: Companies Providing T4 DNA Ligase Kits Table 4: Companies Providing E.coli DNA Ligase Table 5: Companies Providing Tth Ligase Table 6: Companies Providing T4RNA Ligase Table 7: Companies Providing Pfu DNA Ligase Table 8: Companies Providing Other DNA Ligase Table 9: Companies Using E.coli Source for Products Table 10: Companies Providing Thermus thermophilus Source for Products Table 11: U.S. Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 12: Canada Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 13: France Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 14: Germany Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 15: U.K. Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 16: Italy Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 17: Spain Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 18: Rest-of-Europe Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 19: China Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 20: Japan Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 21: India Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 22: Australia Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 23: South Korea Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 24: Rest-of-Asia-Pacific Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 25: Brazil Ligase Market, by Application, $Million, 2022, 2026, 2032 Table 26: Mexico Ligase Market (by Application), $Million, 2022, 2026, 2032 GLOBAL LIGASE MARKET Table 27: Rest-of-LATAM Ligase Market (by Application), $Million, 2022, 2026, 2032 Table 28: Rest-of-the-World Ligase Market (by Application), $Million, 2022, 2026, 2032 16 All rights reserved at BIS Research Inc.

  17. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More GLOBAL LIGASE MARKET Know More 17 All rights reserved at BIS Research Inc.

  18. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 GLOBAL LIGASE MARKET 18 All rights reserved at BIS Research Inc.

  19. BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center GLOBAL LIGASE MARKET Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com 19 All rights reserved at BIS Research Inc.

More Related